Weight-loss (GLP-1 mimicking) drugs may help prevent further tissue damage following a heart attack, significantly reducing the risk of further life-threatening complications that affect up to half of ...

A narrow 10–7 vote ended GLP-1 coverage for state employees, citing high premium costs and a tight state budget.

The Garfield Re-2 school board on Wednesday discussed the rate of renewal of insurance with Emma Dahlin from Willis Towers ...

Preliminary study finds GLP-1 drugs (semaglutide, etc.) are associated with 10% fewer emergency visits and lower medication use for chronic migraine patients.

Social media influencers and supplement companies have stoked concerns, but experts say the issue is a lot more complicated.

Cost-effectiveness is highly price-sensitive; lower U.S. prices, particularly approaching European levels, shift semaglutide toward favorable value rather than a binary go/no-go determination. Patient ...

For people with chronic migraine, taking glucagon-like peptide-1 receptor agonists, or GLP-1 drugs, for other conditions such ...

About 4% of GLP-1 users developed osteoporosis, compared with a little over 3% of nonusers — an increased risk of about 30%.

For people with chronic migraine, taking glucagon-like peptide-1 receptor agonists, or GLP-1 drugs, for other conditions such as diabetes and weight loss, was associated with fewer emergency ...

Your premium access has ended, but the best of Nation.Africa is still within reach. Renew now to unlock exclusive stories and ...

GLP-1s were first approved in 2005 for the treatment of Type 2 diabetes. Since then, more versions of the medication have hit the market, becoming more accessible to patients and used for a wider ...

GLP-1 medications are everywhere, but what happens when appetite suppression meets a culture obsessed with thinness?